Preferential susceptibility of Th9 and Th2 CD4 + T cells to X4-tropic HIV-1 infection

AIDS

Volumn 31, Issue 16, 2017, Pages 2211-2215

  Orlova Fink, Nina ^a   Chowdhury, Fatema Z ^a   Sun, Xiaoming ^a   Harrington, Sean ^a   Rosenberg, Eric S ^b   Yu, Xu G ^a,c   Lichterfeld, Mathias ^a,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD4+ T cell polarization; HIV 1; viral tropism

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 9; CXCR4 PROTEIN, HUMAN; VIRUS RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SANGER SEQUENCING; SURFACE PROPERTY; TH1 CELL; TH17 CELL; TH2 CELL; TH9 CELL; VESICULOVIRUS; VIRUS REPLICATION; X4 TROPIC HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; GROWTH, DEVELOPMENT AND AGING; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; T LYMPHOCYTE SUBPOPULATION; VIRAL TROPISM; VIROLOGY;

HIV-1; HUMANS; RECEPTORS, CXCR4; RECEPTORS, HIV; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; VIRAL TROPISM;

EID: 85030766442     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001630     Document Type: Article

References (18)

1. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (M). Annu Rev Immunol 2010; 28:445-489.
2. Glimcher LH, Murphy KM. Lineage commitment in the immune system: The T helper lymphocyte grows up. Genes Dev 2000; 14:1693-1711.
3. Kaplan MH. Th9 cells: Differentiation and disease. Immunol Rev 2013; 252:104-115.
4. Muranski P, Restifo NP. Essentials of Th17 cell commitment and plasticity. Blood 2013; 121:2402-2414.
5. Schmitt N, Ueno H. Regulation of human helper T cell subset differentiation by cytokines. Curr Opin Immunol 2015; 34:130-136.
6. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5(R)CD4(R) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011; 34:108-121.
7. Gosselin A, Monteiro P, Chomont N, Diaz-Griffero F, Said EA, Fonseca S, et al. Peripheral blood CCR4RCCR6R and CXCR3RCCR6RCD4R T cells are highly permissive to HIV-1 infection. J Immunol 2010; 184:1604-1616.
8. Vicenzi E, Panina-Bodignon P, Vallanti G, Di Lucia P, Poli G. Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(R) T cells. J Leukoc Biol 2002; 72:913-920.
9. Moonis M, Lee B, Bailer RT, Luo Q, Montaner LJ. CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells. AIDS 2001; 15:1941-1949.
10. Josefsson L, Eriksson S, Sinclair E, Ho T, Killian M, Epling L, et al. Hematopoietic precursor cells isolated from patients on longterm suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis 2012; 206:28-34.
11. Sharkey M, Babic DZ, Greenough T, Gulick R, Kuritzkes DR, Stevenson M. Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure. PLoS Pathog 2011; 7:e1001303.
12. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-1599.
13. Lee GQ, Orlova-Fink N, Einkauf K, Chowdhury FZ, Sun X, Harrington S, et al. Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4R T cells. J Clin Invest 2017; 127:2689-2696.
14. Vegran F, Apetoh L, Ghiringhelli F. Th9 cells: A novel CD4 T-cell subset in the immune war against cancer. Cancer Res 2015; 75:475-479.
15. Schmitt E, Klein M, Bopp T. Th9 cells, new players in adaptive immunity. Trends Immunol 2014; 35:61-68.
16. Bruner KM, Murray AJ, Pollack RA, Soliman MG, Laskey SB, Capoferri AA, et al. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med 2016; 22:1043-1049.
17. Stone D, Kiem HP, Jerome KR. Targeted gene disruption to cure HIV. Curr Opin HIV AIDS 2013; 8:217-223.
18. Buzon MJ, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, et al. HIV-1 persistence in CD4R T cells with stem cell-like properties. Nat Med 2014; 20:139-142.